Monday, December 23, 2024
HomeTagsImmunotherapytherapeutics

immunotherapytherapeutics

StemCyte signs a cooperation agreement with a cutting-edge US immune cell therapy company to supply drug preparation raw materials for allogeneic modified cell therapy

As international demand for starting substances for use in cell therapy emerges, California-based regenerative therapeutics company StemCyte announced it has signed a cooperation agreement with...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics